Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2020

Aug 25, 2020

32853_dirs_2020-08-24_deee4c0a-85b0-49a2-b3f8-7940bf1da4fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2020-08-20

Reporting Person: McCracken Colin (Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-20 Common Stock M 2597 Acquired 17823 Direct
2020-08-20 Common Stock M 1531 Acquired 19354 Direct
2020-08-20 Common Stock F 1698 $7.91 Disposed 17656 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-08-20 Restricted Stock Units $ M 2597 Disposed Common Stock (2597.0) Direct
2020-08-20 Restricted Stock Units $ M 1531 Disposed Common Stock (1531.0) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F3: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.